Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 5/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | TNKS | O95271 | 1/20 | 0.41 |
| ▸ | AHR | P35869 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32664934 | 0.81 | ALDH1A1 (0.56) | ALDH1A1KDM4ESMN1; SMN2HPGDMEN1 | |
| SCHEMBL15364821 | 0.81 | ALDH1A1 (0.50) | ALDH1A1KDM4ESMN1; SMN2HPGDMEN1 | |
| SCHEMBL16456325 | 0.80 | KDM4E (0.55) | ALDH1A1KDM4ESMN1; SMN2HPGDMEN1 | |
| SCHEMBL24401671 | 0.79 | DPP4 (0.54) | ALDH1A1KDM4ESMN1; SMN2HPGDLMNA | |
| SCHEMBL32665417 | 0.79 | DYRK3 (0.58) | ALDH1A1KDM4ESMN1; SMN2HPGDKMT2A | |
| SCHEMBL29617977 | 0.79 | DPP4 (0.54) | ALDH1A1KDM4ESMN1; SMN2HPGDLMNA | |
| SCHEMBL14852007 | 0.79 | HPGD (0.53) | ALDH1A1KDM4ESMN1; SMN2HPGDMEN1 | |
| SCHEMBL15365749 | 0.79 | HSD17B10 (0.58) | ALDH1A1KDM4ESMN1; SMN2HPGDMEN1 | |
| SCHEMBL4784567 | 0.78 | BRD4 (0.65) | ALDH1A1KDM4ESMN1; SMN2HPGDKMT2A | |
| SCHEMBL12874554 | 0.77 | DYRK3 (0.60) | ALDH1A1KDM4ESMN1; SMN2HPGDLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022124-A1 | THERAPEUTIC COMPOUNDS AND METHODS | UNIV MINNESOTA (US) | 2026-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022124-A1 | THERAPEUTIC COMPOUNDS AND METHODS | NR5A1, CYP17A1, CNR1 | ALDH1A1 663/4885KDM4E 1972/4885SMN1; SMN2 3155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.